Drugs / I-123-MNI-168
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00870519 | Jan 2009 → Dec 2010 | Alzheimer disease | Institute for Neurodegenerative Disorders | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | I-123-MNI-168 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00870519 ↗ |
| Modality | Diagnostic / imaging agent | “SPECT brain imaging agent” NCT00870519 ↗ |